RENOVORX, INC. Debt Securities, Available-for-sale, Unrealized Gain
RENOVORX, INC. (RNXT) reported Debt Securities, Available-for-sale, Unrealized Gain of $17.00 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Income Statement › Other Income
us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedGain · last filed 2024-04-01
- RENOVORX, INC. debt securities, available-for-sale, unrealized gain for the quarter ending 2023-09-30 was $0.00.
- RENOVORX, INC. debt securities, available-for-sale, unrealized gain for the quarter ending 2023-06-30 was $0.00.
- RENOVORX, INC. debt securities, available-for-sale, unrealized gain for the quarter ending 2023-03-31 was $17.00K.
- RENOVORX, INC. debt securities, available-for-sale, unrealized gain for the quarter ending 2022-12-31 was $4.00K.
- RENOVORX, INC. debt securities, available-for-sale, unrealized gain for fiscal 2022 was $17.00K.
| Period end | Debt Securities, Available-for-sale, Unrealized Gain 3 month | Debt Securities, Available-for-sale, Unrealized Gain 6 month | Debt Securities, Available-for-sale, Unrealized Gain 9 month | Debt Securities, Available-for-sale, Unrealized Gain 12 month |
|---|---|---|---|---|
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $0.00 derived: sum of 2 quarters · filed 2023-11-13 | $17.00K 10-Q · filed 2023-11-13 | $21.00K derived: sum of 4 quarters · filed 2024-04-01 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-16 | $17.00K 10-Q · filed 2023-08-16 | $21.00K derived: sum of 3 quarters · filed 2024-04-01 | |
| 2023-03-31 | $17.00K 10-Q · filed 2023-05-12 | $21.00K derived: sum of 2 quarters · filed 2024-04-01 | ||
| 2022-12-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $17.00K 10-K · filed 2024-04-01 | ||
| 2022-09-30 | $13.00K 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |